Norway vs United Arab Emirates: Average non-HDL cholesterol levels
Norway
3.5
in 2018
United Arab Emirates
3.5
in 2018
Norway rank
52nd
United Arab Emirates rank
52nd
Average non-HDL cholesterol levels over time
- Norway
- United Arab Emirates
How they compare
Norway currently reports 3.5 against 3.5 in United Arab Emirates, a difference of 0.
The two have swapped places 3 times across 39 shared years of data; in 1980 it was Norway ahead.
Norway ranks 52nd and United Arab Emirates ranks 52nd of 191 countries.
Norway has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Norway | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 4.67 | 3.9 | 0.77 | Norway |
| 1990s | 4.35 | 3.87 | 0.48 | Norway |
| 2000s | 3.94 | 3.75 | 0.19 | Norway |
| 2010s | 3.61 | 3.56 | 0.0556 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Norway or United Arab Emirates?
- Norway, at 3.5 against 3.5 in United Arab Emirates as of 2018.
- What is the difference in average non-hdl cholesterol levels between Norway and United Arab Emirates?
- 0, with Norway ahead.
- How many years of comparable data are there for Norway and United Arab Emirates?
- 39 years are reported by both, from 1980 to 2018.
- How do Norway and United Arab Emirates rank globally for average non-hdl cholesterol levels?
- Norway ranks 52nd and United Arab Emirates ranks 52nd of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.